SK Bioscience Co Ltd
KRX:302440

Watchlist Manager
SK Bioscience Co Ltd Logo
SK Bioscience Co Ltd
KRX:302440
Watchlist
Price: 45 350 KRW -1.84%
Market Cap: 3.6T KRW
Have any thoughts about
SK Bioscience Co Ltd?
Write Note

Relative Value

The Relative Value of one SK Bioscience Co Ltd stock under the Base Case scenario is 56 544.56 KRW. Compared to the current market price of 45 350 KRW, SK Bioscience Co Ltd is Undervalued by 20%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
56 544.56 KRW
Undervaluation 20%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
82
vs Industry
43
Median 3Y
12.4
Median 5Y
12.6
Industry
8.1
Forward
15.9
vs History
36
vs Industry
1
Median 3Y
101.6
Median 5Y
106.6
Industry
23
Forward
-70.2
vs History
71
vs Industry
3
Median 3Y
34.7
Median 5Y
37.2
Industry
23.4
vs History
45
vs Industry
Median 3Y
27.1
Median 5Y
42.3
Industry
27.3
vs History
95
vs Industry
37
Median 3Y
3.3
Median 5Y
3.5
Industry
2.6
vs History
80
vs Industry
43
Median 3Y
9.5
Median 5Y
9.9
Industry
8.1
Forward
10.9
vs History
69
vs Industry
25
Median 3Y
19.8
Median 5Y
21.2
Industry
9.6
vs History
39
vs Industry
1
Median 3Y
45.7
Median 5Y
59.1
Industry
4.3
Forward
-52.2
vs History
8
vs Industry
0
Median 3Y
23.3
Median 5Y
35.5
Industry
3.8
Forward
-35.3
vs History
69
vs Industry
3
Median 3Y
28.3
Median 5Y
29.4
Industry
6
vs History
8
vs Industry
Median 3Y
22.4
Median 5Y
35.7
Industry
3.8
vs History
93
vs Industry
32
Median 3Y
6.5
Median 5Y
7.1
Industry
4.8

Multiples Across Competitors

Competitors Multiples
SK Bioscience Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
SK Bioscience Co Ltd
KRX:302440
3.5T KRW 9.4 127 61.5 732.3
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 563 478.2 -178 533.6 -216 796.7 -214 322.8
US
Abbvie Inc
NYSE:ABBV
301B USD 5.4 59.2 14.8 22.8
US
Amgen Inc
NASDAQ:AMGN
162B USD 5 38.3 17.8 33.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
127.5B USD 12 -265.7 26.9 28.2
US
Gilead Sciences Inc
NASDAQ:GILD
115.4B USD 4.1 916 10.2 10.2
US
Epizyme Inc
F:EPE
94.1B EUR 1 875.5 -478.6 -521.2 -507.3
AU
CSL Ltd
ASX:CSL
138B AUD 6 33.9 20.9 26
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
88.6B USD 6.4 19 17.5 19.4
US
Seagen Inc
F:SGT
39.3B EUR 18.1 -55.4 -59.5 -53.7
NL
argenx SE
XBRU:ARGX
34.1B EUR 18.5 -129.9 -104.5 -76.1
P/E Multiple
Earnings Growth
KR
SK Bioscience Co Ltd
KRX:302440
Average P/E: 198.9
127
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -178 533.6 N/A
US
Abbvie Inc
NYSE:ABBV
59.2
412%
US
Amgen Inc
NASDAQ:AMGN
38.3
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -265.7
42%
US
Gilead Sciences Inc
NASDAQ:GILD
916
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -478.6 N/A
AU
CSL Ltd
ASX:CSL
33.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.4 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -129.9 N/A
EV/EBITDA Multiple
EBITDA Growth
KR
SK Bioscience Co Ltd
KRX:302440
Average EV/EBITDA: 24.2
61.5
21%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 796.7 N/A
US
Abbvie Inc
NYSE:ABBV
14.8
28%
US
Amgen Inc
NASDAQ:AMGN
17.8
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.9
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -521.2 N/A
AU
CSL Ltd
ASX:CSL
20.9
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.5
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.5 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -104.5 N/A
EV/EBIT Multiple
EBIT Growth
KR
SK Bioscience Co Ltd
KRX:302440
Average EV/EBIT: 124.7
732.3
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -214 322.8 N/A
US
Abbvie Inc
NYSE:ABBV
22.8
88%
US
Amgen Inc
NASDAQ:AMGN
33.7
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28.2
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.2
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -507.3 N/A
AU
CSL Ltd
ASX:CSL
26
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.1 N/A

See Also

Discover More
Back to Top